Horizon Pharma plc to Present at the Morgan Stanley Global Healthcare Conference

DUBLIN, IRELAND--(Marketwired - Sep 9, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Chairman, President and Chief Executive Officer Timothy P. Walbert will participate in a fireside chat discussion at the Morgan Stanley Global Healthcare Conference in New York on Thursday, September 17^th at 5:15 p.m. Eastern Time. Mr. Walbert will provide an overview of Horizon Pharma's business as well as recent and proposed transactions.

The discussion will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:
Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations
[e-mail]

Tina Ventura
Vice President, Investor Relations
[e-mail]

U.S. Media:
Geoff Curtis
Group Vice President, Corporate Communications
[e-mail]